REGULATE-PCI: REG1 with an unacceptable rate of severe allergic reactions

The aim of this study was to assess treatment with the new anticoagulant Pegnivacogin and its specific antidote Anivamersen compared with bivalirudin in patients undergoing coronary angioplasty. The Pegnivacogin has an affinity for factor IXa with a longer shelf life to 24 hours and Anivamersen only has an affinity for Pegnivacogin. The combination of these two agents is called REG1. Patients who received coronary angioplasty were randomized to the REG1 system (n = 1616) versus bivalirudin (n = 1616). Prior to randomization, the investigator should specify the access site (femoral / radial), the use or not of a vascular closure device and dual anti-aggregation (clopidogrel, prasugrel or ticagrelor).

The work had to be terminated prematurely because of an excess of serious allergic reactions to pegnivacogin. Upon completion 3232 patients were included from 13200 planned. The primary end point of death, stroke and urgent revascularization at 3 days occurred in 6.7% of the REG1 group versus 6.4% of bivalirudin group (p = 0.72).

Roxana Mehran
2015-03-16

Original title: Effect of REG1 Anticoagulation System vs. Bivalirudin on Cardiovascular Outcomes Following PCI.

More articles by this author

PROMISE: Functional Test versus tomography for diagnosis of coronary artery disease

This is the first randomized controlled trial to compare the effectiveness of a functional test versus angiography by tomography (≥64 cuts) to diagnose coronary...

PEGASUS-TIMI 54: Ticagrelor plus ASA in stable patients

This double-blind study included 21162 patients with a history of acute myocardial infarction randomized to ticagrelor 90 mg e/12 h, ticagrelor 60 mg e/12...

PARTNER to 5 years. TAVR is an effective alternative to surgery in high risk patients

This study included 699 patients with severe aortic stenosis and high surgical risk of whom 348 received transcatheter aortic valve replacement (TAVR) and 351...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...